167 filings
Page 5 of 9
424B5
ymc asc11d0
20 Oct 20
Prospectus supplement for primary offering
4:58pm
8-K
ezaos9qyc3hge dqlr
20 Oct 20
Regulation FD Disclosure
4:37pm
8-K
zpcdb0tjyf 5ofla
19 Oct 20
Replimune Appoints Tanya Lewis to the Board of Directors
5:13pm
8-K
sds6pyd p2mwv4g239g
14 Oct 20
Replimune Announces Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
5:14pm
8-K
xzrwug9l4
10 Sep 20
Submission of Matters to a Vote of Security Holders
4:01pm
EFFECT
oxf6u9p acxykkigr
27 Aug 20
Notice of effectiveness
12:15am
8-K/A
ro5lnt7u12
25 Aug 20
Entry into a Material Definitive Agreement
4:45pm
CORRESP
j8454gxm0vg76e2no
25 Aug 20
Correspondence with SEC
12:00am
UPLOAD
uzhr9zs2
13 Aug 20
Letter from SEC
12:00am
8-K
iw0dj rt9
11 Aug 20
Entry into a Material Definitive Agreement
5:16pm
8-K
47c67
7 Aug 20
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update
4:25pm
8-K
mafy3sv6v66m kh
7 Aug 20
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update
4:24pm
8-K
t5phm5nrtc cc59q54wo
22 Jul 20
Departure of Directors or Certain Officers
8:12am
8-K
hie7y0w4hxa5l9
1 Jul 20
Other Events
6:03am
8-K
c29xt
10 Jun 20
Replimune Announces Proposed Public Offering
4:27pm
424B5
qq95j7
10 Jun 20
Prospectus supplement for primary offering
4:04pm
424B5
yqrhrjec4rltnx5v 9x5
8 Jun 20
Prospectus supplement for primary offering
4:44pm